Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gastric Cancer

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    August 2018
  1. COMPANIONI O, Bonet C, Garcia N, Lazaro MJR, et al
    Genetic variation analysis in a follow-up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14.
    Int J Cancer. 2018 Aug 31. doi: 10.1002/ijc.31839.
    PubMed     Text format     Abstract available


  2. GYAWALI B, Kesselheim AS, D'Andrea E
    Does Helicobacter pylori eradication therapy to prevent gastric cancer increase all-cause mortality?
    Int J Cancer. 2018 Aug 28. doi: 10.1002/ijc.31772.
    PubMed     Text format     Abstract available


    July 2018
  3. CHENG L, Qiu L, Zhang R, Qian D, et al
    Functional variant of MTOR rs2536 and survival of Chinese gastric cancer patients.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31656.
    PubMed     Text format     Abstract available


    June 2018
  4. NDEGWA N, Ploner A, Liu Z, Roosaar A, et al
    Association between poor oral health and gastric cancer: A prospective cohort study.
    Int J Cancer. 2018 Jun 6. doi: 10.1002/ijc.31614.
    PubMed     Text format     Abstract available


    May 2018
  5. MIZUGUCHI A, Takai A, Shimizu T, Matsumoto T, et al
    Genetic features of multicentric/multifocal intramucosal gastric carcinoma.
    Int J Cancer. 2018 May 1. doi: 10.1002/ijc.31578.
    PubMed     Text format     Abstract available


    April 2018
  6. SHAO L, Li P, Ye J, Chen J, et al
    Risk of gastric cancer among patients with gastric intestinal metaplasia.
    Int J Cancer. 2018 Apr 29. doi: 10.1002/ijc.31571.
    PubMed     Text format     Abstract available


    March 2018
  7. KIYOZUMI Y, Iwatsuki M, Kurashige J, Ogata Y, et al
    PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.
    Int J Cancer. 2018 Mar 30. doi: 10.1002/ijc.31410.
    PubMed     Text format     Abstract available


  8. KIM H, Keum N, Giovannucci EL, Fuchs CS, et al
    Garlic intake and gastric cancer risk: results from two large prospective US cohort studies.
    Int J Cancer. 2018 Mar 23. doi: 10.1002/ijc.31396.
    PubMed     Text format     Abstract available


    February 2018
  9. KIM HJ, Kang SK, Kwon WS, Kim TS, et al
    Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor.
    Int J Cancer. 2018 Feb 13. doi: 10.1002/ijc.31304.
    PubMed     Text format     Abstract available


  10. HILL DG, Yu L, Gao H, Balic JJ, et al
    Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development.
    Int J Cancer. 2018 Feb 8. doi: 10.1002/ijc.31298.
    PubMed     Text format     Abstract available


    December 2017
  11. WANG W, Li Z, Wang J, Du M, et al
    A functional polymorphism in TFF1 promoter is associated with the risk and prognosis of gastric cancer.
    Int J Cancer. 2017 Dec 6. doi: 10.1002/ijc.31197.
    PubMed     Text format     Abstract available


    October 2017
  12. RHYU MG, Oh JH, Hong SJ
    Species-specific role of gene-adjacent retroelements in human and mouse gastric carcinogenesis.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31120.
    PubMed     Text format     Abstract available


  13. LUO G, Zhang Y, Guo P, Wang L, et al
    Global patterns and trends in stomach cancer incidence: Age, period and birth cohort analysis.
    Int J Cancer. 2017;141:1333-1344.
    PubMed     Text format     Abstract available


    July 2017
  14. LIU X, Zhang X, Zhang Z, Chang J, et al
    Plasma MicroRNA-based Signatures to Predict 3-year Postoperative Recurrence Risk for Stage II and III Gastric Cancer.
    Int J Cancer. 2017 Jul 19. doi: 10.1002/ijc.30895.
    PubMed     Text format     Abstract available


  15. ROTA M, Pelucchi C, Bertuccio P, Matsuo K, et al
    Alcohol consumption and gastric cancer risk - A pooled analysis within the StoP Project Consortium.
    Int J Cancer. 2017 Jul 18. doi: 10.1002/ijc.30891.
    PubMed     Text format     Abstract available


  16. TAKEGAWA N, Nonagase Y, Yonesaka K, Sakai K, et al
    DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance.
    Int J Cancer. 2017 Jul 5. doi: 10.1002/ijc.30870.
    PubMed     Text format     Abstract available


  17. YU G, Hu N, Wang L, Wang C, et al
    Gastric microbiota features associated with cancer risk factors and clinical outcomes: A pilot study in gastric cardia cancer patients from Shanxi, China.
    Int J Cancer. 2017;141:45-51.
    PubMed     Text format     Abstract available


    June 2017
  18. KORSAK B, Almeida GM, Rocha S, Pereira C, et al
    Porphyrin Modified Trastuzumab Improves Efficacy of HER2 Targeted Photodynamic Therapy of Gastric Cancer.
    Int J Cancer. 2017 Jun 22. doi: 10.1002/ijc.30844.
    PubMed     Text format     Abstract available


    May 2017
  19. MIRANTI EH, Stolzenberg-Solomon R, Weinstein SJ, Selhub J, et al
    Low Vitamin B12 Increases Risk of Gastric Cancer: A Prospective Study of One-Carbon Metabolism Nutrients and Risk of Upper Gastrointestinal Tract Cancer.
    Int J Cancer. 2017 May 31. doi: 10.1002/ijc.30809.
    PubMed     Text format     Abstract available


  20. WANG X, Zhou Q, Yu Z, Wu X, et al
    Cancer-associated Fibroblast-derived Lumican Promotes Gastric Cancer Progression via the integrin beta1-FAK signaling pathway.
    Int J Cancer. 2017 May 23. doi: 10.1002/ijc.30801.
    PubMed     Text format     Abstract available


  21. JAKSZYN P, Fonseca-Nunes A, Lujan-Barroso L, Aranda N, et al
    Hepcidin levels and gastric cancer risk in the EPIC-EurGast Study.
    Int J Cancer. 2017 May 22. doi: 10.1002/ijc.30797.
    PubMed     Text format     Abstract available


    April 2017
  22. BUSBY J, Murchie P, Murray L, Iversen L, et al
    The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: a nested case-control study of routine Scottish data.
    Int J Cancer. 2017;140:1828-1835.
    PubMed     Text format     Abstract available


    February 2017
  23. RONCHETTI L, Melucci E, De Nicola F, Goeman F, et al
    DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
    Int J Cancer. 2017 Feb 24. doi: 10.1002/ijc.30668.
    PubMed     Text format     Abstract available


  24. MUHAMMAD JS, Nanjo S, Ando T, Yamashita S, et al
    Autophagy Impairment by Helicobacter pylori-induced Methylation Silencing of MAP1LC3Av1 Promotes Gastric Carcinogenesis.
    Int J Cancer. 2017 Feb 18. doi: 10.1002/ijc.30657.
    PubMed     Text format     Abstract available


    December 2016
  25. BRUSSELAERS N, Maret-Ouda J, Konings P, El-Serag HB, et al
    Menopausal hormone therapy and the risk of esophageal and gastric cancer.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30588.
    PubMed     Text format     Abstract available


  26. PIETRANTONIO F, Caporale M, Morano F, Scartozzi M, et al
    HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research.
    Int J Cancer. 2016;139:2859-2864.
    PubMed     Text format     Abstract available


    October 2016
  27. WANG T, Cai H, Sasazuki S, Tsugane S, et al
    Fruit and Vegetable Consumption, Helicobacter pylori Antibodies, and Gastric Cancer Risk: A Pooled Analysis of Prospective Studies in China, Japan and Korea.
    Int J Cancer. 2016 Oct 19. doi: 10.1002/ijc.30477.
    PubMed     Text format     Abstract available


  28. NAGASE H, Takeoka T, Urakawa S, Morimoto-Okazawa A, et al
    ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori.
    Int J Cancer. 2016 Oct 18. doi: 10.1002/ijc.30475.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: